Index RUT
P/E 5.41
EPS (ttm) 6.01
Insider Own 22.63%
Shs Outstand 120.44M
Perf Week 0.30%
Market Cap 3.81B
Forward P/E 170.19
EPS next Y 0.19
Insider Trans 61.73%
Shs Float 90.64M
Perf Month 4.19%
Income 779.40M
PEG -
EPS next Q -1.40
Inst Own 80.54%
Short Float 13.46%
Perf Quarter -19.24%
Sales 37.25B
P/S 0.10
EPS this Y -117.42%
Inst Trans -5.40%
Short Ratio 5.12
Perf Half Y -43.17%
Book/sh 53.48
P/B 0.61
EPS next Y 109.69%
ROA 5.55%
Short Interest 12.20M
Perf Year -31.58%
Cash/sh 11.67
P/C 2.78
EPS next 5Y -
ROE 12.66%
52W Range 30.17 - 62.88
Perf YTD -26.07%
Dividend Est. 1.01 (3.10%)
P/FCF 4.27
EPS past 5Y 71.82%
ROI 9.56%
52W High -48.32%
Beta 1.56
Dividend TTM 1.00 (3.08%)
Quick Ratio 0.75
Sales past 5Y 17.16%
Gross Margin 4.08%
52W Low 7.72%
ATR (14) 1.25
Dividend Ex-Date Aug 15, 2024
Current Ratio 1.42
EPS Y/Y TTM -74.66%
Oper. Margin 3.20%
RSI (14) 48.34
Volatility 3.33% 4.04%
Employees 3776
Debt/Eq 0.33
Sales Y/Y TTM -11.43%
Profit Margin 2.09%
Recom 3.19
Target Price 33.46
Option/Short Yes / Yes
LT Debt/Eq 0.30
EPS Q/Q -107.08%
Payout 5.15%
Rel Volume 0.26
Prev Close 33.07
Sales Surprise 1.13%
EPS Surprise -235.20%
Sales Q/Q -4.60%
Earnings Oct 31 BMO
Avg Volume 2.38M
Price 32.50
SMA20 0.13%
SMA50 -1.33%
SMA200 -26.80%
Trades
Volume 105,780
Change -1.73%
Date
Action
Analyst
Rating Change
Price Target Change
Oct-17-24 Resumed
BofA Securities
Underperform
$25
Oct-04-24 Downgrade
BMO Capital Markets
Outperform → Market Perform
$42 → $35
Oct-02-24 Downgrade
JP Morgan
Overweight → Neutral
$53 → $40
Sep-20-24 Downgrade
Piper Sandler
Neutral → Underweight
$47 → $25
Sep-09-24 Downgrade
Tudor, Pickering, Holt & Co.
Hold → Sell
Jul-18-24 Resumed
Wolfe Research
Peer Perform
May-03-24 Reiterated
TD Cowen
Hold
$54 → $45
Mar-22-24 Downgrade
Mizuho
Buy → Neutral
$53 → $58
Mar-15-24 Upgrade
BofA Securities
Neutral → Buy
$52 → $74
Feb-16-24 Reiterated
TD Cowen
Market Perform
$35 → $41
Jan-24-24 Initiated
Citigroup
Neutral
Jan-03-24 Upgrade
Mizuho
Neutral → Buy
$52
Oct-05-23 Initiated
BMO Capital Markets
Outperform
$60
Aug-15-23 Downgrade
BofA Securities
Buy → Neutral
$46 → $56
May-19-23 Downgrade
Mizuho
Buy → Neutral
$56 → $41
Mar-09-23 Initiated
UBS
Neutral
$53
Jan-10-23 Resumed
Mizuho
Buy
$43 → $50
Sep-21-22 Upgrade
JP Morgan
Neutral → Overweight
$43
Sep-15-22 Upgrade
Wolfe Research
Underperform → Outperform
$36 → $49
Jun-14-22 Upgrade
Wells Fargo
Equal Weight → Overweight
$57
Show Previous Ratings
Oct-21-24 08:06AM
Oct-17-24 01:03PM
12:50PM
Oct-12-24 09:44AM
Oct-11-24 06:30PM
08:06AM
Loading…
Oct-06-24 08:06AM
Sep-03-24 04:15PM
Aug-31-24 03:10PM
Aug-26-24 11:18AM
Aug-05-24 09:42AM
Aug-01-24 07:45AM
06:44AM
(Associated Press Finance)
06:30AM
Jul-25-24 10:02AM
Jul-05-24 10:33AM
08:00PM
Loading…
Jun-26-24 08:00PM
Jun-24-24 01:44PM
Jun-20-24 01:26PM
Jun-14-24 02:04PM
Jun-13-24 01:36PM
Jun-06-24 01:49PM
May-14-24 11:57AM
May-09-24 09:40AM
May-03-24 12:00PM
09:55AM
07:45AM
03:16AM
May-02-24 11:17PM
(Thomson Reuters StreetEvents)
11:35AM
10:54AM
10:46AM
Loading…
10:46AM
08:03AM
07:45AM
06:58AM
06:40AM
(Associated Press Finance)
06:30AM
Apr-30-24 01:37PM
Apr-29-24 09:40AM
Apr-25-24 10:02AM
Apr-23-24 09:40AM
08:50AM
Apr-19-24 08:25AM
Apr-11-24 09:40AM
Apr-05-24 12:00PM
08:50AM
Mar-27-24 01:01PM
01:00PM
08:20AM
Mar-21-24 07:01PM
Mar-18-24 10:54AM
Mar-14-24 08:48AM
Mar-12-24 10:14AM
Mar-01-24 01:41PM
Feb-21-24 07:00AM
(The Wall Street Journal)
Feb-16-24 11:07AM
09:16AM
Feb-15-24 11:58PM
(Thomson Reuters StreetEvents)
09:30AM
07:40AM
07:17AM
06:45AM
(Associated Press Finance)
06:39AM
06:34AM
06:30AM
Feb-08-24 10:00AM
Feb-07-24 12:36PM
Feb-06-24 05:17PM
Feb-02-24 12:10PM
Jan-31-24 06:46PM
Jan-25-24 09:40AM
Jan-22-24 01:13PM
Dec-18-23 02:18PM
01:05PM
Dec-10-23 09:20PM
Dec-07-23 09:40AM
09:39AM
Dec-06-23 03:59PM
Dec-04-23 08:32AM
Nov-26-23 11:08AM
Nov-22-23 09:40AM
Nov-21-23 09:40AM
Nov-15-23 10:41AM
Nov-08-23 09:35AM
Nov-07-23 06:52PM
Nov-06-23 11:07AM
09:40AM
Nov-03-23 09:39AM
12:51AM
(Thomson Reuters StreetEvents)
Nov-02-23 09:40AM
09:30AM
08:50AM
07:17AM
06:56AM
(Associated Press Finance)
06:30AM
Nov-01-23 08:44PM
10:25AM
Oct-30-23 04:07PM
10:00AM
Oct-27-23 07:21AM
Oct-26-23 02:50PM
PBF Energy, Inc. engages in the operation of a petroleum refinery and supplies unbranded transportation fuels, heating oil, petrochemical feed stocks, lubricants, and other petroleum products in the United States. It operates through the Refining and Logistics segments. The Refining segment is involved in refining crude oil and other feed stocks into petroleum products. The Logistics segment includes owning, leasing, operation, development, and acquisition of crude oil and refined petroleum products terminals, pipelines, storage facilities, and logistics assets. The company was founded on March 1, 2008 and is headquartered in Parsippany, NJ.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Oct 15 '24 Buy 31.75 1,000,000 31,752,400 24,462,398 Oct 17 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Oct 16 '24 Buy 31.80 2,000 63,600 24,464,398 Oct 17 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 30 '24 Buy 30.85 55,000 1,696,624 23,462,398 Oct 02 04:21 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 24 '24 Buy 31.79 150,000 4,767,915 23,367,398 Sep 26 05:25 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 25 '24 Buy 30.93 40,000 1,237,024 23,407,398 Sep 26 05:25 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 23 '24 Buy 31.87 265,000 8,445,391 23,217,398 Sep 24 06:38 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 20 '24 Buy 31.78 250,000 7,946,100 22,952,398 Sep 24 06:38 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 11 '24 Buy 31.29 670,000 20,964,233 22,527,398 Sep 13 05:53 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 12 '24 Buy 31.25 175,000 5,469,135 22,702,398 Sep 13 05:53 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 10 '24 Buy 31.86 470,000 14,972,414 21,857,398 Sep 11 04:10 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 09 '24 Buy 32.17 300,000 9,650,460 21,387,398 Sep 11 04:10 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 05 '24 Buy 32.62 805,300 26,266,067 20,634,898 Sep 09 04:38 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 06 '24 Buy 32.15 452,500 14,547,287 21,087,398 Sep 09 04:38 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 04 '24 Buy 33.31 700,000 23,313,850 19,829,598 Sep 05 07:14 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 03 '24 Buy 33.18 510,000 16,919,505 19,129,598 Sep 05 07:14 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 27 '24 Buy 32.73 175,000 5,727,505 18,619,598 Aug 28 04:10 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 26 '24 Buy 33.30 92,000 3,064,042 18,444,598 Aug 28 04:10 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 07 '24 Buy 36.47 73,000 2,662,222 18,352,598 Aug 09 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 06 '24 Buy 35.96 100,000 3,595,620 18,279,598 Aug 07 04:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 05 '24 Buy 35.60 50,000 1,780,125 18,179,598 Aug 07 04:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 01 '24 Buy 39.22 307,000 12,039,803 18,079,598 Aug 05 06:19 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 02 '24 Buy 37.28 50,000 1,863,785 18,129,598 Aug 05 06:19 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 27 '24 Buy 45.07 179,000 8,066,814 17,632,598 Jul 01 08:41 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 28 '24 Buy 45.73 140,000 6,402,097 17,772,598 Jul 01 08:41 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 26 '24 Buy 44.91 102,000 4,580,769 17,453,598 Jun 27 06:11 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 25 '24 Buy 44.10 44,000 1,940,338 17,351,598 Jun 27 06:11 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 21 '24 Buy 44.00 600,000 26,397,060 17,207,598 Jun 25 06:52 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 24 '24 Buy 44.31 100,000 4,431,210 17,307,598 Jun 25 06:52 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 20 '24 Buy 43.84 365,200 16,009,236 16,607,598 Jun 21 04:02 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 18 '24 Buy 43.36 200,300 8,685,909 16,242,398 Jun 21 04:02 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 14 '24 Buy 44.13 600,000 26,475,600 16,004,098 Jun 18 06:25 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 17 '24 Buy 43.65 38,000 1,658,833 16,042,098 Jun 18 06:25 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 12 '24 Buy 44.36 403,400 17,896,357 15,286,098 Jun 14 04:01 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 13 '24 Buy 43.89 118,000 5,178,701 15,404,098 Jun 14 04:01 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 07 '24 Buy 46.19 51,000 2,355,466 14,875,198 Jun 11 04:53 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 10 '24 Buy 45.65 7,500 342,359 14,882,698 Jun 11 04:53 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 05 '24 Buy 45.37 200,000 9,073,080 14,824,198 Jun 07 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 04 '24 Buy 45.27 195,000 8,826,850 14,624,198 Jun 05 05:25 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 03 '24 Buy 44.96 84,000 3,776,917 14,429,198 Jun 05 05:25 PM Nimbley Thomas J. Executive Chairman May 17 '24 Option Exercise 24.43 50,000 1,221,500 763,377 May 20 07:13 PM Davis Paul T Senior Vice President Mar 25 '24 Option Exercise 27.66 100,000 2,766,000 210,978 Mar 27 10:49 AM Davis Paul T Senior Vice President Mar 25 '24 Sale 56.37 100,000 5,637,230 110,978 Mar 27 10:49 AM O Connor Thomas L Senior Vice President Mar 25 '24 Option Exercise 30.89 10,000 308,900 170,338 Mar 27 10:49 AM O Connor Thomas L Senior Vice President Mar 25 '24 Sale 57.15 10,000 571,500 160,338 Mar 27 10:49 AM O Connor Thomas L Senior Vice President Mar 19 '24 Option Exercise 30.89 40,000 1,235,600 200,338 Mar 21 03:15 PM O Connor Thomas L Senior Vice President Mar 19 '24 Sale 55.87 40,000 2,234,600 160,338 Mar 21 03:15 PM O Connor Thomas L Senior Vice President Mar 14 '24 Option Exercise 30.89 40,000 1,235,600 200,338 Mar 15 06:21 PM O Connor Thomas L Senior Vice President Mar 14 '24 Sale 55.07 40,000 2,202,922 160,338 Mar 15 06:21 PM Lucey Matthew C. CEO & President Mar 07 '24 Option Exercise 24.43 50,000 1,221,500 330,897 Mar 08 04:58 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jan 24 '24 Buy 43.86 12,200 535,133 14,345,198 Jan 26 04:06 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jan 17 '24 Buy 41.57 500,000 20,784,550 14,332,998 Jan 19 04:11 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jan 16 '24 Buy 42.95 770,000 33,070,653 13,832,998 Jan 17 04:20 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jan 12 '24 Buy 42.48 486,000 20,644,162 13,062,998 Jan 17 04:20 PM Lucey Matthew C. CEO & President Dec 19 '23 Option Exercise 24.75 50,000 1,237,500 289,293 Dec 20 05:55 PM Canty Trecia M SVP and General Counsel Dec 19 '23 Option Exercise 24.75 10,000 247,500 99,587 Dec 20 05:53 PM Canty Trecia M SVP and General Counsel Dec 19 '23 Sale 46.69 10,000 466,863 89,587 Dec 20 05:53 PM
Index RUT
P/E 347.18
EPS (ttm) 0.03
Insider Own 25.26%
Shs Outstand 180.15M
Perf Week -1.94%
Market Cap 1.70B
Forward P/E -
EPS next Y -0.19
Insider Trans 20.12%
Shs Float 134.64M
Perf Month -14.07%
Income -16.26M
PEG -
EPS next Q -0.06
Inst Own 80.91%
Short Float 9.84%
Perf Quarter -18.80%
Sales 1.75B
P/S 0.97
EPS this Y -146.27%
Inst Trans 4.54%
Short Ratio 5.56
Perf Half Y -30.21%
Book/sh 15.13
P/B 0.62
EPS next Y -80.87%
ROA -0.29%
Short Interest 13.25M
Perf Year -39.78%
Cash/sh 0.21
P/C 45.01
EPS next 5Y -
ROE -0.68%
52W Range 9.52 - 16.19
Perf YTD -33.64%
Dividend Est. -
P/FCF 16.31
EPS past 5Y -20.25%
ROI -0.38%
52W High -41.67%
Beta 1.93
Dividend TTM -
Quick Ratio 0.80
Sales past 5Y 20.65%
Gross Margin 18.46%
52W Low -0.81%
ATR (14) 0.39
Dividend Ex-Date -
Current Ratio 0.80
EPS Y/Y TTM -99.18%
Oper. Margin 16.26%
RSI (14) 33.17
Volatility 2.93% 3.66%
Employees 600
Debt/Eq 0.59
Sales Y/Y TTM 23.99%
Profit Margin -0.93%
Recom 1.33
Target Price 16.68
Option/Short Yes / Yes
LT Debt/Eq 0.58
EPS Q/Q -38.05%
Payout 0.00%
Rel Volume 0.62
Prev Close 9.73
Sales Surprise 6.30%
EPS Surprise 146.15%
Sales Q/Q 49.55%
Earnings Aug 07 AMC
Avg Volume 2.39M
Price 9.44
SMA20 -9.24%
SMA50 -13.88%
SMA200 -21.89%
Trades
Volume 253,593
Change -2.95%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-19-24 Initiated
Mizuho
Outperform
$16
Jul-22-24 Initiated
Goldman
Buy
$14
Mar-22-24 Initiated
Citigroup
Buy
$16.50
Nov-21-23 Initiated
Canaccord Genuity
Buy
$24
Apr-25-23 Initiated
Stephens
Overweight
$21
Mar-23-23 Initiated
KeyBanc Capital Markets
Overweight
$18
Oct-20-22 Resumed
Stifel
Buy
$27
Jul-20-22 Resumed
MKM Partners
Buy
$23
Apr-14-22 Initiated
Stephens
Overweight
$28
Jan-10-22 Downgrade
BMO Capital Markets
Outperform → Market Perform
$14 → $12.50
Nov-03-21 Initiated
The Benchmark Company
Buy
$23
Aug-26-21 Upgrade
KeyBanc Capital Markets
Sector Weight → Overweight
$15
Jun-08-21 Initiated
Citigroup
Buy
$19
Dec-09-20 Downgrade
KeyBanc Capital Markets
Overweight → Sector Weight
Sep-14-20 Initiated
Northland Capital
Outperform
Jul-15-20 Initiated
Stifel
Buy
$17
Jun-25-20 Initiated
MKM Partners
Buy
$17
Jun-04-20 Initiated
BMO Capital Markets
Outperform
$16
Apr-14-20 Initiated
KeyBanc Capital Markets
Overweight
$12
Mar-13-20 Downgrade
ROTH Capital
Buy → Neutral
Show Previous Ratings
Oct-16-24 09:40AM
Oct-09-24 05:45PM
Oct-01-24 05:44PM
08:58AM
01:36AM
06:58AM
Loading…
Sep-17-24 06:58AM
Sep-13-24 03:31PM
Sep-05-24 12:37PM
06:58AM
Aug-30-24 02:21PM
06:58AM
Aug-26-24 06:58AM
Aug-07-24 06:15PM
05:15PM
(Associated Press Finance)
04:33PM
10:41AM
Loading…
Aug-06-24 10:41AM
Aug-01-24 02:21AM
Jul-22-24 08:01AM
06:58AM
Jul-11-24 06:58AM
Jun-28-24 08:35AM
Jun-03-24 02:11PM
May-29-24 06:58AM
May-22-24 09:35AM
May-15-24 06:58AM
May-09-24 01:30PM
May-08-24 04:23PM
03:33AM
May-07-24 10:01AM
04:34AM
09:54PM
Loading…
May-06-24 09:54PM
06:51PM
06:35PM
05:34PM
(Associated Press Finance)
04:15PM
12:51PM
Apr-29-24 10:00AM
Apr-25-24 04:15PM
12:42PM
Apr-19-24 12:15PM
Apr-10-24 06:58AM
Mar-19-24 08:00AM
Mar-18-24 02:24PM
09:34AM
09:00AM
Mar-14-24 04:14PM
08:25AM
08:00AM
Mar-13-24 07:00PM
Mar-11-24 04:24PM
Mar-07-24 08:00AM
Mar-06-24 07:00PM
Mar-05-24 10:02AM
Mar-04-24 04:30PM
Feb-29-24 11:42PM
(Thomson Reuters StreetEvents)
06:05PM
09:50AM
06:36AM
Feb-28-24 09:30PM
08:45PM
07:47PM
(Associated Press Finance)
07:27PM
07:05PM
Feb-21-24 10:00AM
Feb-12-24 04:57PM
04:39PM
Feb-06-24 10:39AM
Feb-01-24 04:15PM
Jan-25-24 04:05PM
09:40AM
01:05AM
Jan-24-24 01:00PM
Jan-23-24 01:20AM
Jan-18-24 09:01AM
07:05AM
Jan-17-24 10:26PM
04:12PM
Jan-15-24 06:09PM
05:46PM
05:40PM
05:33PM
Jan-08-24 05:41PM
Jan-04-24 11:49AM
Jan-03-24 06:58AM
Dec-29-23 07:50AM
Dec-22-23 06:58AM
Dec-20-23 08:30AM
Dec-18-23 09:14AM
Dec-15-23 08:50AM
Dec-07-23 07:00AM
Dec-01-23 05:32PM
(The Wall Street Journal)
04:30PM
Nov-17-23 08:32AM
Nov-14-23 06:58AM
Nov-08-23 01:55PM
04:47AM
(Thomson Reuters StreetEvents)
Nov-07-23 10:10AM
06:44AM
Nov-06-23 08:00PM
06:00PM
(Associated Press Finance)
Talos Energy, Inc. operates as a holding company. The firm engages in the exploration and production of oil and natural gas. It focuses on the exploration, acquisition, exploitation and development of shallow and deepwater assets near existing infrastructure in the United State Gulf of Mexico. The company was founded by John A. Parker, Stephen E. Heitzman and Timothy S. Duncan in 2012 and is headquartered in Houston, TX.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 27 '24 Buy 10.31 100,000 1,030,980 43,545,604 Oct 01 04:41 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 26 '24 Buy 10.19 336,700 3,430,502 43,445,604 Sep 27 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 25 '24 Buy 10.52 250,000 2,628,825 43,108,904 Sep 27 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 05 '24 Buy 10.84 323,000 3,502,612 42,858,904 Sep 09 04:35 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 04 '24 Buy 11.12 1,850,000 20,571,815 42,535,904 Sep 05 07:11 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Sep 03 '24 Buy 10.92 547,000 5,975,319 40,685,904 Sep 05 07:11 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 07 '24 Buy 10.38 650,000 6,744,010 40,138,904 Aug 09 04:06 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 05 '24 Buy 9.99 343,000 3,428,148 39,488,904 Aug 07 04:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 02 '24 Buy 10.96 617,000 6,761,765 39,145,904 Aug 05 06:21 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Aug 01 '24 Buy 11.50 306,000 3,518,602 38,528,904 Aug 05 06:21 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jul 30 '24 Buy 11.40 250,000 2,850,000 38,222,904 Aug 01 04:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 18 '24 Buy 10.80 300,000 3,240,000 37,972,904 Jun 21 04:07 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 May 30 '24 Buy 11.45 1,400,000 16,030,000 37,672,904 May 31 06:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 May 29 '24 Buy 11.48 200,000 2,296,980 36,272,904 May 31 06:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 May 23 '24 Buy 11.51 150,000 1,725,780 36,072,904 May 31 06:15 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 15 '24 Buy 12.82 60,556 776,328 35,922,904 Mar 19 04:45 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 14 '24 Buy 12.80 645,838 8,267,372 35,862,348 Mar 15 04:06 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 13 '24 Buy 12.77 468,729 5,987,825 35,216,510 Mar 15 04:06 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jan 17 '24 Buy 11.70 19,658,119 229,999,992 34,747,781 Jan 19 08:21 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Nov 13 '23 Buy 14.20 140,251 1,991,186 15,089,662 Nov 15 09:00 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Nov 09 '23 Buy 14.09 1,058,481 14,912,621 14,949,411 Nov 13 04:05 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Nov 08 '23 Buy 13.61 498,930 6,791,385 13,890,930 Nov 13 04:05 PM
Index RUT
P/E -
EPS (ttm) -0.59
Insider Own 39.17%
Shs Outstand 126.05M
Perf Week -6.15%
Market Cap 230.68M
Forward P/E -
EPS next Y -0.53
Insider Trans 168.58%
Shs Float 76.68M
Perf Month -19.56%
Income -38.68M
PEG -
EPS next Q -0.13
Inst Own 36.65%
Short Float 13.07%
Perf Quarter -23.75%
Sales 0.00M
P/S -
EPS this Y 12.21%
Inst Trans 17.02%
Short Ratio 14.67
Perf Half Y -32.47%
Book/sh -7.73
P/B -
EPS next Y -5.20%
ROA -7.87%
Short Interest 10.02M
Perf Year 2.24%
Cash/sh 3.42
P/C 0.53
EPS next 5Y -
ROE -
52W Range 1.12 - 4.44
Perf YTD 2.81%
Dividend Est. -
P/FCF -
EPS past 5Y -
ROI -
52W High -58.78%
Beta 1.28
Dividend TTM -
Quick Ratio 21.87
Sales past 5Y 0.00%
Gross Margin -
52W Low 63.40%
ATR (14) 0.16
Dividend Ex-Date -
Current Ratio 21.87
EPS Y/Y TTM 0.59%
Oper. Margin 0.00%
RSI (14) 45.36
Volatility 8.01% 9.70%
Employees 163
Debt/Eq -
Sales Y/Y TTM -
Profit Margin -
Recom 2.00
Target Price 4.80
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q -16.71%
Payout -
Rel Volume 0.12
Prev Close 1.85
Sales Surprise -
EPS Surprise 36.76%
Sales Q/Q -
Earnings Aug 09 BMO
Avg Volume 683.10K
Price 1.83
SMA20 2.03%
SMA50 -13.66%
SMA200 -14.15%
Trades
Volume 14,537
Change -1.08%
Date
Action
Analyst
Rating Change
Price Target Change
Sep-30-24 Initiated
JP Morgan
Neutral
Sep-10-24 Initiated
Guggenheim
Buy
$6
Mar-07-24 Resumed
Morgan Stanley
Equal-Weight
$3
Jan-02-24 Downgrade
BofA Securities
Buy → Neutral
Jul-25-23 Initiated
BTIG Research
Buy
$16
Dec-21-22 Initiated
Jefferies
Buy
$15
Nov-10-22 Initiated
Morgan Stanley
Equal-Weight
$13
Oct-18-22 Initiated
UBS
Buy
$18
Oct-14-22 Initiated
Citigroup
Buy
$16
Sep-23-22 Initiated
BofA Securities
Buy
$14
Sep-02-22 Initiated
Evercore ISI
Outperform
Show Previous Ratings
Oct-22-24 07:02PM
Oct-14-24 07:30AM
Oct-09-24 07:30AM
Sep-04-24 01:33PM
(Clinical Trials Arena) -9.17%
Sep-03-24 07:30AM
07:30AM
Loading…
Aug-27-24 07:30AM
Aug-09-24 07:00AM
Jun-27-24 05:52AM
Jun-26-24 02:10PM
Jun-17-24 07:00AM
Jun-11-24 09:35PM
(GlobeNewswire) -19.87%
+23.55%
07:40AM
Jun-10-24 04:15PM
07:32AM
06:30AM
07:00AM
Loading…
May-29-24 07:00AM
May-21-24 07:00AM
May-10-24 03:43PM
01:54PM
07:48AM
07:00AM
Mar-25-24 06:05AM
Mar-21-24 07:49PM
Feb-29-24 04:05PM
Dec-29-23 08:22AM
Dec-13-23 09:55AM
Nov-30-23 06:05AM
Nov-24-23 06:40AM
Nov-21-23 06:05AM
Nov-17-23 01:38PM
09:35AM
Loading…
Nov-16-23 09:35AM
Nov-14-23 07:04AM
06:05AM
Nov-13-23 05:02PM
Oct-30-23 04:12PM
Oct-17-23 09:35AM
Oct-16-23 02:50PM
Oct-12-23 03:05PM
Sep-06-23 12:14PM
(American City Business Journals)
Sep-05-23 06:05AM
Aug-31-23 10:33AM
Aug-29-23 01:16PM
(American City Business Journals)
Aug-11-23 02:21PM
(American City Business Journals)
Aug-10-23 04:10PM
Jul-18-23 06:05AM
Jul-17-23 06:05AM
Jun-13-23 12:05PM
Jun-01-23 04:05PM
May-11-23 04:01PM
May-04-23 06:05AM
Apr-25-23 02:00PM
Mar-28-23 04:12PM
Mar-03-23 06:05AM
Jan-11-23 07:48AM
Jan-10-23 04:05PM
Dec-27-22 11:05AM
08:46AM
Dec-22-22 06:05AM
Nov-16-22 11:22AM
Nov-14-22 06:05AM
Nov-11-22 04:05PM
Nov-03-22 06:05AM
Oct-14-22 12:00PM
Sep-23-22 06:15AM
Sep-08-22 06:05AM
Aug-31-22 06:05AM
Aug-11-22 05:30PM
10:01AM
Jul-20-22 08:00AM
ProKidney Corp. is a clinical-stage biotechnology company, which engages in the development of a proprietary cell therapy platform. The firm focuses on the treatment of chronic kidney disease, shifting the emphasis away from management of kidney failure to the restoration of kidney function to stop or delay progression of CKD. It offers REACT, a product candidate that includes selected renal cells prepared from a patient's own, autologous, and renal cells. The company was founded on December 21, 2015 and is headquartered in Winston-Salem, NC.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Weber Darin J. Chief Regulatory Officer Sep 19 '24 Sale 2.50 16,412 41,030 103,480 Sep 20 04:44 PM DARIN J WEBER Officer Sep 19 '24 Proposed Sale 2.39 16,412 39,225 Sep 19 04:27 PM Weber Darin J. Chief Regulatory Officer Jul 26 '24 Sale 2.50 826 2,065 119,892 Jul 29 04:02 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Jun 11 '24 Buy 2.42 8,264,462 19,999,998 71,560,107 Jun 25 04:06 PM Weber Darin J. Chief Regulatory Officer Jun 18 '24 Sale 2.82 17,238 48,616 120,718 Jun 20 04:03 PM Legorreta Pablo G. Director Jun 13 '24 Buy 2.42 22,617,909 54,735,340 22,617,909 Jun 14 04:05 PM Weber Darin J. Chief Regulatory Officer May 20 '24 Sale 4.08 17,238 70,386 137,956 May 22 07:22 AM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 13 '24 Buy 1.50 50,000 75,090 63,168,645 May 16 08:22 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 14 '24 Buy 1.36 50,000 67,925 63,218,645 May 16 08:22 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 20 '24 Buy 1.40 33,000 46,111 63,251,645 May 16 08:22 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 25 '24 Buy 1.43 30,000 42,954 63,295,645 May 16 08:22 PM Control Empresarial de Capital Add'l Rep. Persons-see Ex.99-1 Mar 22 '24 Buy 1.40 14,000 19,586 63,265,645 May 16 08:22 PM Weber Darin J. SVP of Regulatory Development Apr 22 '24 Sale 2.51 16,438 41,315 155,194 Apr 23 04:05 PM Weber Darin J. SVP of Regulatory Development Apr 18 '24 Sale 2.54 800 2,028 171,632 Apr 23 04:05 PM Weber Darin J. SVP of Regulatory Development Apr 16 '24 Sale 2.50 17,238 43,095 172,432 Apr 17 06:57 PM Weber Darin J. SVP of Regulatory Development Apr 12 '24 Sale 1.73 84,103 145,498 189,670 Apr 16 04:54 PM Weber Darin J. SVP of Regulatory Development Apr 01 '24 Sale 1.69 300 507 273,773 Apr 16 04:54 PM Palihapitiya Chamath Former 10% Owner Nov 19 '23 Sale 1.31 7,256,367 9,498,584 0 Nov 21 06:30 AM Palihapitiya Chamath 10% Owner Nov 15 '23 Sale 1.49 282,300 420,147 5,653,867 Nov 17 09:00 PM Palihapitiya Chamath 10% Owner Nov 17 '23 Sale 1.19 258,400 308,400 5,183,367 Nov 17 09:00 PM Palihapitiya Chamath 10% Owner Nov 16 '23 Sale 1.22 212,100 259,398 5,441,767 Nov 17 09:00 PM Palihapitiya Chamath 10% Owner Nov 14 '23 Sale 1.50 306,200 459,086 5,936,167 Nov 14 09:15 PM Palihapitiya Chamath 10% Owner Nov 09 '23 Sale 1.68 95,900 160,700 6,416,967 Nov 14 09:15 PM Palihapitiya Chamath 10% Owner Nov 13 '23 Sale 1.57 88,700 139,676 6,242,367 Nov 14 09:15 PM Palihapitiya Chamath 10% Owner Nov 10 '23 Sale 1.61 85,900 138,411 6,331,067 Nov 14 09:15 PM Palihapitiya Chamath 10% Owner Nov 06 '23 Sale 1.56 79,600 123,818 6,643,100 Nov 08 09:00 PM Palihapitiya Chamath 10% Owner Nov 07 '23 Sale 1.59 71,233 113,367 6,571,867 Nov 08 09:00 PM Palihapitiya Chamath 10% Owner Nov 08 '23 Sale 1.66 59,000 97,763 6,512,867 Nov 08 09:00 PM Palihapitiya Chamath 10% Owner Nov 03 '23 Sale 1.73 148,300 256,470 6,722,700 Nov 03 09:00 PM Palihapitiya Chamath 10% Owner Nov 02 '23 Sale 1.73 133,700 231,956 6,871,000 Nov 03 09:00 PM Palihapitiya Chamath 10% Owner Nov 01 '23 Sale 1.62 123,400 199,674 7,004,700 Nov 03 09:00 PM Palihapitiya Chamath 10% Owner Oct 30 '23 Sale 1.65 157,000 259,537 7,270,000 Oct 31 09:30 PM Palihapitiya Chamath 10% Owner Oct 31 '23 Sale 1.69 141,900 239,300 7,128,100 Oct 31 09:30 PM Palihapitiya Chamath 10% Owner Oct 27 '23 Sale 1.59 92,500 146,677 7,427,000 Oct 31 09:30 PM Palihapitiya Chamath 10% Owner Oct 24 '23 Sale 1.75 176,300 308,613 7,664,673 Oct 26 09:00 PM Palihapitiya Chamath 10% Owner Oct 26 '23 Sale 1.80 77,960 140,577 7,519,500 Oct 26 09:00 PM Palihapitiya Chamath 10% Owner Oct 25 '23 Sale 1.76 67,213 118,382 7,597,460 Oct 26 09:00 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite